In a study published in the Biochemical and Biophysical Research Journal, researchers found promising results for a new less invasive tool in diagnosing mesothelioma. The method involves combining the blood levels of mesothelin (a biomarker for mesothelioma) and measuring portions of a soluble protein called Megakaryocyte Potentiating Factor (MPF).
The German Researchers, developed a cost effective way to detect MPF with a test called MPF ELISA. ELISA is an acronym for enzyme-linked immunosorbent assay. The test combined with the mesothlin bio-marker makes the test more accurate.
“There is still a lack of validated biomarkers for the early detection of mesothelioma. The most promising marker so far is mesothelin, but a single marker is not sufficient to reach adequate sensitivity.”
When the MPF ELISA Test was combined with mesothelin blood levels it increased the overall accuracy of the test by 3% - from 77% to 80%. Based on these results researchers are hopeful that several other less invasive tests may be combined with the mesothelim blood and ELISA test to make diagnosing mesothelioma less invasive.
The Paul Law Firm advocates for victims of asbestos-related diseases. If you or a loved one is suffering from mesothelioma, call the Paul Law Firm. With over 2.5 billion dollars collected for victims of asbestos exposure, we have the knowledge and the experience to fight for you. We also understand that fighting doesn’t just happen in the courtroom. It also happens in a lab where we are fighting for a cure. Check out the Mesothelioma Research Foundation of America here.
Call us today at 1-855 88 LEGAL (885-3425) or contact us online to discuss your case with one of our experienced mesothelioma lawyers.